106 related articles for article (PubMed ID: 21684074)
21. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
22. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
23. OCT4B expression in PBMNCs suggests the existence of an alternative OCT4 promoter.
Papamichos SI; Lambropoulos AF; Kotoula V
Genes Chromosomes Cancer; 2009 Dec; 48(12):1112-4. PubMed ID: 19760603
[No Abstract] [Full Text] [Related]
24. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
25. Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types.
Rodriguez RT; Velkey JM; Lutzko C; Seerke R; Kohn DB; O'Shea KS; Firpo MT
Exp Biol Med (Maywood); 2007 Nov; 232(10):1368-80. PubMed ID: 17959850
[TBL] [Abstract][Full Text] [Related]
26. OCT4 expression in human uterine myometrial stem/progenitor cells.
Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
[TBL] [Abstract][Full Text] [Related]
27. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
28. Expression analysis and characterization of alternatively spliced transcripts of human IL-7Ralpha chain encoding two truncated receptor proteins in relapsed childhood all.
Korte A; Köchling J; Badiali L; Eckert C; Andreae J; Geilen W; Kebelmann-Betzing C; Taube T; Wu S; Henze G; Seeger K
Cytokine; 2000 Nov; 12(11):1597-608. PubMed ID: 11052810
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
30. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues.
Liang Y; Li C; Guzman VM; Chang WW; Evinger AJ; Sao D; Woodward DF
FEBS J; 2005 Feb; 272(3):791-9. PubMed ID: 15670159
[TBL] [Abstract][Full Text] [Related]
32. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
33. Reprogramming of trophoblast stem cells into pluripotent stem cells by Oct4.
Wu T; Wang H; He J; Kang L; Jiang Y; Liu J; Zhang Y; Kou Z; Liu L; Zhang X; Gao S
Stem Cells; 2011 May; 29(5):755-63. PubMed ID: 21305674
[TBL] [Abstract][Full Text] [Related]
34. Human corneal basal epithelial cells express an embryonic stem cell marker OCT4.
Zhou SY; Zhang C; Baradaran E; Chuck RS
Curr Eye Res; 2010 Nov; 35(11):978-85. PubMed ID: 20958186
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.
Cheng CJ; Wu YC; Shu JA; Ling TY; Kuo HC; Wu JY; Chang EE; Chang SC; Huang YH
J Biomed Sci; 2007 Nov; 14(6):797-807. PubMed ID: 17682839
[TBL] [Abstract][Full Text] [Related]
36. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.
Hu T; Liu S; Breiter DR; Wang F; Tang Y; Sun S
Cancer Res; 2008 Aug; 68(16):6533-40. PubMed ID: 18701476
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines.
Mirzaei MR; Najafi A; Arababadi MK; Asadi MH; Mowla SJ
Tumour Biol; 2014 Oct; 35(10):9999-10009. PubMed ID: 25008565
[TBL] [Abstract][Full Text] [Related]
40. A PCR/restriction digestion assay for the detection of the transcript variants 1 and 2 of POU5F1.
Panagopoulos I; Möller E; Isaksson M; Mertens F
Genes Chromosomes Cancer; 2008 Jun; 47(6):521-9. PubMed ID: 18335506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
